All Journals > Infection Control and Hospital Epidemiology > March 2008 > Interhospital Comparison of Antibacterial Use

Article Tools

Search for Related Articles

Highlighted Article

NHSN Annual Update:
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections

Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Antimicrobial-resistant pathogens that cause healthcare-associated infections (HAIs) pose an ongoing and increasing challenge to hospitals, both in the clinical treatment of patients and in the prevention of the cross-transmission of these problematic pathogens.  Describing the magnitude of the problem with respect to these antimicrobial-resistant pathogens is challenging, because the levels of antimicrobial resistance vary for different types of healthcare facilities and for different geographic areas, and some resistance phenotypes are difficult for laboratories to detect. However, the findings from such attempts may help the infection control and public health communities target problems and utilize resources more efficiently.

In the News

Featured in The Times
"Ireland 'losing war' on superbug" February 15, 2009
Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin‐Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland
Fidelma Fitzpatrick, MD; Fiona Roche, PhD; Robert Cunney, MB; Hilary Humphreys, MD; Strategy for the Control of Antimicrobial Resistance in Ireland Infection Control Subcommittee
The research, published in Infection Control and Hospital Epidemiology, found one third of hospitals did not have a written policy on antibiotic use, and only 35% had an antibiotic stewardship programme.

March 2008

Volume 29, Number 3
Infect Control Hosp Epidemiol 2008;29:203–211
0899-823X/2008/2903-0002$15.00
DOI: 10.1086/528810
Original Article

Variability in Rates of Use of Antibacterials Among 130 US Hospitals and Risk‐Adjustment Models for Interhospital Comparison

Conan MacDougall, PharmD;

Ronald E. Polk, PharmD

From the Department of Clinical Pharmacy, School of Pharmacy, University of California–San Francisco, San Francisco, California (C.M.); Department of Pharmacy, School of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, Virginia (R.E.P.).

Objective.To describe variability in rates of antibacterial use in a large sample of US hospitals and to create risk‐adjusted models for interhospital comparison.

Methods.We retrospectively surveyed the use of 87 antibacterial agents on the basis of electronic claims data from 130 medical‐surgical hospitals in the United States for the period August 2002 to July 2003; these records represented 1,798,084 adult inpatients. Hospitals were assigned randomly to the derivation data set (65 hospitals) or the validation data set (65 hospitals). Multivariable models predicting rates of antibacterial use were created using the derivation data set. These models were then used to predict rates of antibacterial use in the validation data set, which was compared with observed rates of antibacterial use. Rates of antibacterial use was measured in days of therapy per 1,000 patient‐days.

Results.Across the surveyed hospitals, a mean of 59.3% of patients received at least 1 dose of an antimicrobial agent during hospitalization (range for individual hospitals, 44.4%‐73.6%). The mean total rate of antibacterial use was 789.8 days of therapy per 1,000 patient‐days (range, 454.4‐1,153.4). The best model for the total rate of antibacterial use explained 31% of the variance in rates of antibacterial use and included the number of hospital beds, the number of days in the intensive care unit per 1,000 patient‐days, the number of surgeries per 1,000 discharges, and the number of cases of pneumonia, bacteremia, and urinary tract infection per 1,000 discharges. Five hospitals in the validation data set were identified as having outlier rates on the basis of observed antibacterial use greater than the upper bound of the 90% prediction interval for predicted antibacterial use in that hospital.

Conclusion.Most adult inpatients receive antimicrobial agents during their hospitalization, but there is substantial variability between hospitals in the volume of antibacterials used. Risk‐adjusted models can explain a significant proportion of this variation and allow for comparisons between hospitals for benchmarking purposes.

Received August 14, 2007; accepted December 5, 2007; electronically published February 1, 2008.

Address reprint requests to Ronald E. Polk, PharmD, Department of Pharmacy, School of Pharmacy, Virginia Commonwealth University, 410 N 12th Street, P.O. Box 980533, Richmond, VA 23298‐053 ().

Cited by

Patricia Pavese, MD; Nathalie Saurel, PharmD; José Labarère, MD; Corinne Decouchon, MD; Jean‐Philippe Vittoz, BSc; Luc Foroni, PharmD; Max Maurin, MD, PhD; Patrice François, MD, PhD. (2009) Does an Educational Session With an Infectious Diseases Physician Reduce the Use of Inappropriate Antibiotic Therapy for Inpatients With Positive Urine Culture Results? A Controlled Before‐and‐After Study •. Infection Control and Hospital Epidemiology 30:6, 596-599
Online publication date: 1-Jun-2009.
Richard H Drew, Roger White, Conan MacDougall, Elizabeth D Hermsen, Robert C Owens, . (2009) Insights from the Society of Infectious Diseases Pharmacists on Antimicrobial Stewardship Guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy 29:5, 593-607
Online publication date: 1-Jun-2009.
CrossRef
Close Popup